A critical review of zebrafish schizophrenia models: time for validation?

Publication date: Available online 2 August 2019Source: Neuroscience & Biobehavioral ReviewsAuthor(s): Kinga Gawel, Nancy Saana Banono, Agnieszka Michalak, Camila V. EsguerraAbstractSchizophrenia is a mental disorder that affects 1% of the population worldwide and is manifested as a broad spectrum of symptoms, from hallucinations to memory impairment. It is believed that genetic and/or environmental factors may contribute to the occurrence of this disease. Recently, the zebrafish has emerged as a valuable and attractive model for various neurological disorders including schizophrenia. In this review, we describe current pharmacological models of schizophrenia with special emphasis on providing insights into the pros and cons of using zebrafish as a behavioural model of this disease. Moreover, we highlight the advantages and utility of using zebrafish for elucidating the genetic mechanisms underlying this psychiatric disorder. We believe that the zebrafish has high potential also in the area of precision medicine and may complement the development of therapeutics, especially for pharmacoresistant patients.
Source: Neuroscience and Biobehavioral Reviews - Category: Neuroscience Source Type: research